Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives

Journal of Autoimmunity

Volumn 12, Issue 4, 1999, Pages 279-287

  Maclaren, Noel ^a   Lan, Michael ^a   Coutant, Regis ^a   Schatz, Desmond ^b   Silverstein, Janet ^b   Muir, Andrew ^b   Clare Salzer, Michael ^b   She, Jin Xiong ^b   Malone, John ^c   Crockett, Samual ^b   Schwartz, Sherwyn ^d   Quattrin, Teresa ^e   Desilva, Mark ^f   Vander Vegt, Pierre ^f   Notkins, Abner ^f   Krischer, Jeffrey ^g  

^a The Research Institute for Children at Children's Hospital New Orleans   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d Humana Columbia Hospital   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Autoantibodies; GAD65; HLA DR DQ; IA 2; IA 2 ; Prediction; Relatives; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; CHILD; FEMALE; HLA SYSTEM; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; INFANT; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULINOMA; MALE; NORMAL HUMAN; PANCREAS INJURY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL;

EID: 0033020127     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0281     Document Type: Article

References (44)

1. Atkinson M.A., Maclaren N.K. The pathogenesis of insulin dependent diabetes. N. Engl. J. Med. 331:1994;1428-1436.
2. Riley W.J., Maclaren N.K., Krisher J.P., Spillar R.P., Silverstein J.H., Schatz D.A., Shah S., Vadheim C.M., Rotter J.I. A prospective study of the development of diabetes in relatives of patients with insulin dependent diabetes. N. Engl. J. Med. 323:1990;1167-1172.
3. Atkinson M.A., Maclaren N.K., Riley W.J., Winter W.Q.E., Fisk D.D., Spillar R.P. Are insulin autoantibody markers for insulin-dependent diabetes mellitus? Diabetes. 35:1986;894-898.
4. Krisher J.P., Schatz S., Riley W.J., Spillar R.P., Silverstein J.H., Schwartz S., Malone J., Shah S., Vadheim C.M., Rotter J.I., Quattrin T., Maclaren N.K. Insulin and islet cell autoantibodies as time dependent covariates in the development of insulin dependent diabetes: a prospective study in relatives. J. Clin. Endocrinol. Metab. 77:1993;743-749.
5. Baekksekov S., Neilsen J.H., Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantibodies in newly diagnosed diabetic children with immunoprecipitate human pancreatic islet cell proteins. Nature. 298:1982;167-169.
6. Kaufman D., Erlander M., Clarre-Salzler M., Atkinson M., Maclaren N., Tobin A. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent mellitus. J. Clin. Invest. 89:1992;283-292.
7. Lan M.S., Wasserfall C., Maclaren N.K., Notkins A.L. IA-2, A transmembrane protein of the protein tyrosine phosphate family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA. 93:1996;6367-6370.
8. Myers M.A., Rabin D.U., Rowley M.J. Pancreatic islet cell cytoplasmic antibodies in diabetes is represented by antibodies to islet cell antigen 512 and glutamin acid decarboxylase. Diabetes. 44:1995;1290-1295.
9. Lu J., Li Q., Xie H., Chen Z., Borovitskaya A.E., Maclaren N.K., Notkins A.L., Lan M.S. Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa-tryptic fragment. Proc. Natl. Acad. Sci. USA. 93:1996;2307-2311.
10. Kawasaki E., Eisenbarth G.S., Wasmeier C., Hutton J.C. Autoantibodies to protein tyrosine phospatase-like proteins in type 1 diabetes. Diabetes. 45:1996;1344-1349.
11. Atkinson M.A., Kaufman D.L., Newman D., Tobin A.J., Maclaren N.K. Islet cell cytoplasmic autoantibody reactivity to gluamate decarboxylase in insulin-dependent diabetes. J. Clin. Invest. 91:1993;350-356.
12. Christie M.R., Tun R.Y., Lo S.S., Cassidy D., Brown T.J., Hollands J., Shattock M., Bottazzo G.F., Leslie R.D. Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Studies with identical twins. Diabetes. 41:1992;782-787.
13. Reimers J.I., Anderson H.U., Pociot F. Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale, effects toxicology and clinical experiences. ENDIT Group. Ugeskr. Laeger. 156:1994;461-465.
14. Skyler J., Marks J. Immune interventions in type I diabetes mellitus. Diabetes Rev. 1:1993;15-42.
15. Vardi P., Dib S.A., Tuttleman M., Connelly J.E., Gribirgs, Riley W., Maclaren N.K., Eisenbarth G.S., Soeldner J.S. Competitive insulin autoantibody assay; prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes. 36:1987;1286-1291.
16. Mehta H.B., Vold B., Minkin S., Ullman E.F. DELISA: sensitive nonisotopic assay for GAD autoantibodies, a key risk-assessment marker for insulin-dependent diabetes mellitus. Clin. Chem. 42:1996;263-269.
17. Cantor A.B., Krisher J.P., Cuthbertson D.D., Schatz D.A., Riley W.J., Malone J., Schwartz S., Quatrin T., Maclaren N.K. Age and family relationship accentuate the risk of IDDM in relatives of patients with insulin dependent diabetes. J. Clin. Endocrinol. Metab. 80:1995;3739-3743.
18. Huang W., Conner E., Dela Rosa T., Muir A., Schatz D., Silverstein J., Crockett S., She J., Maclaren N.K. Although DR3-DQB1* may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta cell autoimmunity. J. Clin. Endocrin. Metabol. 81:1996;1-5.
19. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
20. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem. Rep. 50:1988;163-170.
21. Schuster J. EXACTB and CONF: exact unconditional procedures for binomial data. Am. Stat. 42:1988;234.
22. Schatz D., DPT-1 Group. The diabetes prevention trial type 1 diabetes (DPT-1): Design and implementation of the oral antigen (insulin) protocol. Diabetes*. 449(Suppl. 1):1995;A230.
23. Schott M., Schatz D., Atkinson M., Krisher J., Mehta H., Vold B., Maclaren N. GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell insulin autoantibodies for developing insulin dependent diabetes mellitus. J. Autoimmun. 7:1994;865-872.
24. Schmidli R.S., Coleman P.G., Harrison L.C. So glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM? J. Autoimmun. 7:1994;873-879.
25. Zimmet P.Z., Tuomi T., Mackay I.R., Rowley M.J., Knowles W., Cohen M., Lang D.A. Latent autoimmune diabetes mellitus in adults (LADA): the role of autoantibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetes Med. 11:1994;299-303.
26. Mayrhofer M., Rabin D.U., Messenger L., Standl E., Zieglen A.G. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes. Exp. Clin. Endocrinol. Diab. 104:1996;228-234.
27. Bingley P.J., Christie M.R., Bonifacio E., Bonfanti R., Shattock M., Fonte M.T., Bottazzo G.F., Gale E.A. Combines analyses of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes. 43:1994;1304-1310.
28. Verge C.F., Gianni R., Kawasaski E., Yu L., Pietropaola, Chase H.P., Eisenbrarth G.S. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specifications determines risk of type 1 diabetes. J. Autoimmun. 9:1996;379-383.
29. Verge C.F., Gianani R., Kawasaki E., Chase H., Eisenbarth G.S. Prediction of type 1 diabetes in first degree relatives using a combination of insulin, GAD and ICA512bc/IA-2 autoantibodies. Diabetes. 45:1996;926-933.
30. Kulmala P., Savola K., Petersen J.S., Vhasalo P., Karjalainen J., Lopponen T., Dyrberg T., Akerblom H.K., Knip M. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. J. Clin. Invest. 101:1998;327-336.
31. Christie M.R., Genovese S., Cassidy D., Bosi E., Brown T.J., Lai M., Bonifacio E., Bottazzo G.F. Antibodies to islet 37 k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes. 43:1994;1254-1259.
32. Ongagna J.C., Levy-Marchal C. Anti-37 kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies. Diabetologia. 38:1995;370-375.
33. Elliott R.B., Pilchner C.C. A universal model of antibody prediction (MAP) of type 1 diabetes in children. J. Autoimmun. 7:1994;881-888.
34. Aanstoot H., Kang S., Kim J., Lindsay L., Roll U., Knip M., Atkinson M.A., Larsen-Mose P., Fey S., Ludvigsson J., Landin M., Bruining J., Maclaren N.K., Akerblom H.K., Baekkeskov S. Identification and characterization of Glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 Diabetes. J. Clin. Invest. 97:1996;2772-2783.
35. Dotta F., Gianni R., Previtit M., Lenti L., Dianisi S., D'Erme M., Eisenbarth G.S., Di-Mario U. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type 1 diabetes. Diabetes. 45:1996;1193-1196.
36. Castano L., Russo E., Zhou L., Lipes M.A., Eisenbarth G.S. Identification and cloning of a granule autoantigen carboxypeptidase-H) associated with type 1 diabetes. J. Clin. Endocrinol. Metab. 73:1991;1197-1201.
37. Buschard K., Josefsen K., Horn T., Fredman P. Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus. Lancet. 342:1993;840.
38. Karounos D.G., Molinsky J.S., Thomas J.W. Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J. Immunol. 150:1993;3080-3085.
39. Boitard C., Villa M.C., Becourt C., Gia H.P., Huc C., Sempe P., Portier M.M., Bach J.F. Peripherin: an islet antigen that is cross-reactive with non-obese diabetic mouse class II gene products. Proc. Natl. Acad. Sci. USA. 89:1992;172-176.
40. Pietropaolo M., Castano L., Babu S., Buelow R., Kuo Y.S., Martin S., Martin A., Powers A.C., Prochazka M., Naggert J., Leiter E.H., Eisenbarth G.S. Islet cell autoantigen 69 kD (ICA69), molecular cloning and characterization of a novel diabetes-associated autoantigen. J. Clin. Invest. 92:1993;359-371.
41. Lampasona V., Ferrari M., Bosi E., Pastore R.M., Bingley P.J., Bonifacio E. Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen. J. Autoimmun. 7:1994;665-674.
42. Vandewalle C.L., Decraene T., Schuit F.C., DeLeeuw I.H., Pipeleers D.G., Gorus F.K. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1* 0302 haplotype at clinical onset of type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. Diabetologia. 36:1993;1155-1162.
43. Sabbah E., Kulmala P., Veijola R., Vahasalo P., Karjalainen J., Tuomilehto-Wolf E., Akerblom H.K., Knip M. Glutamic acid decarboxylase antibodies in relations to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 81:1996;2455-2459.
44. Moudgil K.D., Chang T.T., Eradat H., Chen A.M., Gupta R.S., Brahm E., Sercarz E.E. Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis. J. Exp. Med. 18:1997;1307-1316.